Skip to main content
Ajay Srivastava, MD, Nephrology, Cincinnati, OH

AjaySrivastavaMD

Nephrology Cincinnati, OH

Assistant Professor, Internal Medicine, Macon, Mercer University School of Medicine

Dr. Srivastava is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Srivastava's full profile

Already have an account?

  • Office

    234 Goodman Street
    222 Piedmont Ave #2200
    Cincinnati, OH 45219
    Phone+1 513-584-4956
    Fax+1 513-584-5571
  • Is this information wrong?

Education & Training

  • University of Rochester
    University of RochesterFellowship, Nephrology, 2006 - 2008
  • University of Rochester
    University of RochesterResidency, Internal Medicine, 2003 - 2006
  • University of Texas Medical Branch School of Medicine
    University of Texas Medical Branch School of MedicineClass of 2003

Certifications & Licensure

  • OH State Medical License
    OH State Medical License 2015 - 2024
  • KY State Medical License
    KY State Medical License 2016 - 2020
  • IN State Medical License
    IN State Medical License 2015 - 2019
  • SC State Medical License
    SC State Medical License 2015 - 2019
  • GA State Medical License
    GA State Medical License 2010 - 2016
  • CA State Medical License
    CA State Medical License 2012 - 2016
  • TX State Medical License
    TX State Medical License 2008 - 2012
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Nephrology
  • Join now to see all

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification Solution Series EHR, e-MDs, 2012-2013

Publications & Presentations

PubMed

Press Mentions

  • Heart and Kidney Health for All: Expanding Cardiovascular Clinical Trials to Include CKD Patients
    Heart and Kidney Health for All: Expanding Cardiovascular Clinical Trials to Include CKD PatientsFebruary 7th, 2024